Researchers at the University of Utah School of
Medicine have mad a discovery that could lead to treatments for two of
the leading causes of blindness – age-related macular degeneration and
diabetic retinopathy. Age-related macular degeneration is the most common
cause of blindness in people age 65 or older and is expected to rise as
our population gets older. And diabetic retinopathy is the most common
cause of blindness in working-age people, and is also on the rise as the
number of people with diabetes goes up. These diseases cause problems by
making blood vessels grow abnormally in the eye – and these new blood vessels
are often weak and leaky.
Human eye cross-sectional view grayscaleThe
team found that eye damage caused by both diseases could be prevented
and even reversed by switching on a protein called Robo-4, which has been
implicated in angiogenesis – the process by which the body grows new blood
vessels. |
Previous research has shown that Robo-4 can stop the growth of new
blood vessels and stabilise them, preventing uncontrolled blood vessel
growth. In experiments with mice, the scientists found that activating
Robo-4 could block abnormal blood vessel growth and stabilise blood vessels
to prevent leakage, helping to prevent or improve the symptoms of age-related
macular degeneration and diabetic retinopathy.
This discovery could pave the way for treatments
that switch on Robo-4, which could be potentially powerful treatments for
blindness caused by these diseases. The research could also have bigger
implications. For example, serious infections such as SARS kill people
when an infection destabilizes blood vessels, allowing fluid to leak into
the lungs. Could activating Robo-4 help to stop this? And in cancer, tumours
hijack blood vessels to provide them with nutrients and oxygen – so could
there be some role for Robo-4 activating drugs here too? |